The Effect of Nonsense Mediated Decay on Transcriptional Activity Within the Novel ß-Thalassemia Mutation HBB: c.129delT
MetadataShow full item record
Premature termination codons (PTCs) are caused by mutations in the coding sequences of functional genes resulting in an incorrect assignment of a stop codon. Abnormal and truncated proteins are prevented from being translated due to the rapid degradation of mRNA carrying these mutations by an RNA surveillance mechanism referred to as nonsense mediated decay (NMD). Recently, a novel mutation in a patient from Thailand with the clinical diagnosis of Hb E (HBB: c.79G > A)/β0-thalassemia (Hb E/β0-thal) and whose molecular analysis demonstrated a novel mutation in the β-globin gene, HBB: c.129delT, was reported. The result of this deletion is a frameshift (FSC) resulting in a PTC at codon 60. We have analyzed the impact of this mutation on transcription and translation of the affected β-globin gene using an in vitro model. The quantitative real-time polymerase chain reaction (qReTi-PCR) analysis revealed that this nucleotide mutation resulted in marked mRNA degradation, which we attributed to the NMD mechanism and as such, the expected deleterious truncated HBB was not generated. This result highlights a valuable application of our in vitro gene expression model that can be used to predict possible molecular pathology for any given nucleotide mutations.
Showing items related by title, author, creator and subject.
Ley, T.; Miller, C.; Ding, L.; Raphael, B.; Mungall, A.; Robertson, G.; Hoadley, K.; Triche, T.; Laird, P.; Baty, J.; Fulton, L.; Fulton, R.; Heath, S.; Kalicki-Veizer, J.; Kandoth, C.; Klco, J.; Koboldt, D.; Kanchi, K.; Kulkarni, S.; Lamprecht, T.; Larson, D.; Lin, G.; Lu, C.; McLellan, M.; McMichael, J.; Payton, J.; Schmidt, H.; Spencer, D.; Tomasson, M.; Wallis, J.; Wartman, L.; Watson, M.; Welch, J.; Wendl, M.; Ally, A.; Balasundaram, M.; Birol, I.; Butterfield, Y.; Chiu, R.; Chu, A.; Chuah, E.; Chun, H.; Corbett, R.; Dhalla, N.; Guin, R.; He, A.; Hirst, C.; Hirst, M.; Holt, R.; Jones, S.; Karsan, A.; Lee, D.; Li, H.; Marra, M.; Mayo, M.; Moore, R.; Mungall, K.; Parker, J.; Pleasance, E.; Plettner, P.; Schein, J.; Stoll, D.; Swanson, L.; Tam, A.; Thiessen, N.; Varhol, Richard; Wye, N.; Zhao, Y.; Gabriel, S.; Getz, G.; Sougnez, C.; Zou, L.; Leiserson, M.; Vandin, F.; Wu, H.; Applebaum, F.; Baylin, S.; Akbani, R.; Broom, B.; Chen, K.; Motter, T.; Nguyen, K.; Weinstein, J.; Zhang, N.; Ferguson, M.; Adams, C.; Black, A.; Bowen, J.; Gastier-Foster, J.; Grossman, T.; Lichtenberg, T.; Wise, L.; Davidsen, T.; Demchok, J.; Mills Shaw, K.; Sheth, M.; Sofia, H.; Yang, L.; Downing, J.; Eley, G. (2013)BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic phenotypes are not yet clear. METHODS: We analyzed ...
Alpha thalassaemia due to non-deletional mutations on the -3.7 alpha globin fusion gene: Laboratory diagnosis and clinical importanceChow, A.; Ghassemifar, Reza; Finlayson, J. (2013)Aims: Alpha (α) thalassaemia may be caused by large deletions of the α globin gene(s), or rarely, non-deletional mutations. Both types of mutations may co-exist, and if located on the same allele (α0), produce a reproductive ...
In vitro characterization of the a-thalassemia point mutation HBA2:c.95+1G>A [IVS-I-1(G>A) (a2)]Qadah, T.; Finlayson, J.; Ghassemifar, Reza (2012)The a-thalassemias are a group of disorders occurring as a result of decreased synthesis of a-globin chains, most commonly due to deletions of a-globin genes. Detection of a-thalassemia (a-thal) caused by point mutations ...